Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Genebanks CRP
•  Crop & tree diversity in
international collections under
Art 15 is secured in perpetuity
•  Conserved cro...
Genebanks CRP
•  Use of conserved crop and tree
diversity is informed and
facilitated
•  Crop & tree diversity is
conserve...
60%	
   40%
Genebanks are Good Value!
•  Cooperation 88 - C88
–  400,000 ha in China
–  Economic benefits US$ 350 m/yr
•  Kasetsart 50...
Genebanks are Good Value!
The 12 most popular accessions in the IRRI genebank
have been used in more than 1000 crosses eac...
Performance Indicators
•  % of total collection available
(viable, disease-free, in sufficient
sample numbers)
•  % of tot...
Performance Indicators
•  % of total collection represented with
passport and characterization data
online
•  Stage (from ...
Online Reporting Tool
9	
  
2013 Status of Availability
10	
  
0%	
  
25%	
  
50%	
  
75%	
  
100%	
  
%	
  available	
  in	
  
2012	
  
%	
  availabl...
0%	
  
25%	
  
50%	
  
75%	
  
100%	
  
%	
  available	
  in	
  
2012	
  
%	
  available	
  in	
  
2013	
  
Target	
  2021...
2013 Status of Availability
12	
  
0%	
  
25%	
  
50%	
  
75%	
  
100%	
  
Bioversity-­‐Banana	
   IITA-­‐Clonal	
   CIP-­...
2013 Status of Security
13	
  
0%	
  
25%	
  
50%	
  
75%	
  
100%	
  
%	
  safety	
  duplicated	
  in	
  
2012	
  
%	
  s...
2013 Status of Security
14	
  
0%	
  
25%	
  
50%	
  
75%	
  
100%	
  
%	
  safety	
  duplicated	
  in	
  
2012	
  
%	
  s...
2013 Status of Security
15	
  
0%	
  
25%	
  
50%	
  
Bioversity-­‐Banana	
   CIP-­‐Total	
   CIAT-­‐Cassava	
   IITA-­‐Cl...
Findings
16	
  
The majority of genebanks will not meet performance
targets by the end of 2016. We believe that they can
r...
External Reviews
17	
  
•  CGN-Netherlands
•  Millennium Seed Bank-UK
•  USDA
•  EMBRAPA
•  IPK-Germany
•  FAO
Reviewers Comments
“The bank appears at a crossroad. A successful future depends on it being used to
maximum potential.”
“...
Reviewers Comments
19	
  
“A genebank must be, especially those
in the CGIAR system, a reliable
repository of germplasm fo...
CGIAR is the Primary User
20	
  
Picture: Neil Palmer/CIAT
Within	
  
CGIAR	
  
62%	
  
Outside	
  
CGIAR	
  
38%	
  
With...
Cost-efficiency
21	
  
0	
  
10	
  
20	
  
30	
  
40	
  
50	
  
60	
  
70	
  
80	
  
90	
  
100	
  
ICRAF	
   ILRI	
   CIA...
Cost-efficiency
22	
  
0	
  
100	
  
200	
  
300	
  
400	
  
500	
  
600	
  
700	
  
800	
  
Bioversity	
   CIP	
   ICRAF	...
Findings
Funding allocations will never be equitable
between Centers nor cost-efficient as long as the
genebanks are runni...
Fund Disbursement Strategy
Principles and criteria of eligibility
•  Materials are Annex 1/Art 15, accessible, important w...
Potential Funding Structure?
Matching funds:
Overheads, research FCR not related to direct
genebank use, capital depreciat...
26	
  
Principles of Partnership
•  Financial and performance commitment on both sides
•  Based on a Business Plan which d...
Thank	
  you	
  
Meeting of the cgiar consortium board and director generals
Upcoming SlideShare
Loading in …5
×

Meeting of the cgiar consortium board and director generals

1,526 views

Published on

o In Dar es Salaam, the Crop Trust presented the status and performance targets of the international crop collections.

Published in: Government & Nonprofit
  • Be the first to comment

  • Be the first to like this

Meeting of the cgiar consortium board and director generals

  1. 1. Genebanks CRP •  Crop & tree diversity in international collections under Art 15 is secured in perpetuity •  Conserved crop & tree germplasm is clean, available and disseminated 2  
  2. 2. Genebanks CRP •  Use of conserved crop and tree diversity is informed and facilitated •  Crop & tree diversity is conserved within a rationalized, cost-effective and globalized system. 3  
  3. 3. 60%   40%
  4. 4. Genebanks are Good Value! •  Cooperation 88 - C88 –  400,000 ha in China –  Economic benefits US$ 350 m/yr •  Kasetsart 50 - KU 50 –  1 million hectares in Thailand & Vietnam –  Aggregate economic benefits > US$ 97 million “Only possible because of conserved germplasm in genebanks” Robinson & Srinivasan, 2013 5  
  5. 5. Genebanks are Good Value! The 12 most popular accessions in the IRRI genebank have been used in more than 1000 crosses each 6   Of 4,317 rice varieties released, 90% non-IRRI varieties and 100% IRRI varieties had at least one genebank accession in its pedigree
  6. 6. Performance Indicators •  % of total collection available (viable, disease-free, in sufficient sample numbers) •  % of total collection secure in long term storage/cryo and safety duplicated plus in SGSV for seed crops 7   > 90% Target
  7. 7. Performance Indicators •  % of total collection represented with passport and characterization data online •  Stage (from 1 to 5) in QMS development •  Average overall satisfaction of genebank users •  % of the collection that is disseminated over a 10-yr period •  Cost efficiency (per accession cost, cost per distribution, number staff) 8  
  8. 8. Online Reporting Tool 9  
  9. 9. 2013 Status of Availability 10   0%   25%   50%   75%   100%   %  available  in   2012   %  available  in   2013   Target  
  10. 10. 0%   25%   50%   75%   100%   %  available  in   2012   %  available  in   2013   Target  2021   2013 Status of Availability 11   Of  the  725,000  accessions  held  by   the  CGIAR,  just  over  480,000  are   actually  available  for  immediate   distribuGon  
  11. 11. 2013 Status of Availability 12   0%   25%   50%   75%   100%   Bioversity-­‐Banana   IITA-­‐Clonal   CIP-­‐Total   CIAT-­‐Cassava   %  available  in  2012   %  available  in  2013   Target    
  12. 12. 2013 Status of Security 13   0%   25%   50%   75%   100%   %  safety  duplicated  in   2012   %  safety  duplicated  in   2013   Target  
  13. 13. 2013 Status of Security 14   0%   25%   50%   75%   100%   %  safety  duplicated  in   2012   %  safety  duplicated  in   2013   Target   Of  the  725,000  accessions  held  by  the  CGIAR,   378,000  are  actually  available  for  immediate   distribuGon  
  14. 14. 2013 Status of Security 15   0%   25%   50%   Bioversity-­‐Banana   CIP-­‐Total   CIAT-­‐Cassava   IITA-­‐Clonal   %  safety  duplicated  in  2012   %  safety  duplicated  in  2013   Target  2025  
  15. 15. Findings 16   The majority of genebanks will not meet performance targets by the end of 2016. We believe that they can reach targets by 2021 through monitored, rationalized and fully supported workplans.
  16. 16. External Reviews 17   •  CGN-Netherlands •  Millennium Seed Bank-UK •  USDA •  EMBRAPA •  IPK-Germany •  FAO
  17. 17. Reviewers Comments “The bank appears at a crossroad. A successful future depends on it being used to maximum potential.” “The operational procedures have grown organically as the need for them arose… The procedures need objective review, critical or redundant areas identified and addressed so that processes are streamlined and fully justifiable” “staff [of two Centers] should engage in discussions and actions that will result in a more rational approach to the conservation of PGR than is presently the case. This should involve the clear delineation of responsibilities for different parts of the genepool, agreement on the archiving of actively managed materials which are held in duplication and concrete mechanisms for closer communication and collaboration, including data sharing and resolution of taxonomic issues.” 18  
  18. 18. Reviewers Comments 19   “A genebank must be, especially those in the CGIAR system, a reliable repository of germplasm for conservation and access…According to the current procedures, the genebank is clearly failing in delivering…as one third of the material is currently not available even though it is presented on the website. This situation is highly undesirable and has the potential to generate damage in terms of public relations for both the genebank and the entire CGIAR”
  19. 19. CGIAR is the Primary User 20   Picture: Neil Palmer/CIAT Within   CGIAR   62%   Outside   CGIAR   38%   Within   CGIAR   69%   Outside   CGIAR   31%   Samples   Accessions   131,181 samples distributed in 2012 •  61,599 accessions within CGIAR •  27,868 outside CGIAR
  20. 20. Cost-efficiency 21   0   10   20   30   40   50   60   70   80   90   100   ICRAF   ILRI   CIAT   Forages   CIAT   Beans   ICRISAT   CIMMYT   Maize   Africa   Rice   IRRI   ICARDA   IITA   CIMMYT   Wheat   USD    per  accession  cost   2012   2013  
  21. 21. Cost-efficiency 22   0   100   200   300   400   500   600   700   800   Bioversity   CIP   ICRAF   CIAT  Cassava   IITA  clonal  crops   USD  per  accession  cost   2012   2013  
  22. 22. Findings Funding allocations will never be equitable between Centers nor cost-efficient as long as the genebanks are running at different levels. We believe we need to pursue other mechanisms than the Costing Study. 23  
  23. 23. Fund Disbursement Strategy Principles and criteria of eligibility •  Materials are Annex 1/Art 15, accessible, important within a rational system Each holder: Ø  commits to long term conservation and availability Ø  works in partnership towards the global system Ø  has links to users Ø  has HR & management system to maintain PGR Ø  can demonstrate conformity with agreed standards Ø  has facilities that are adequate for LTS 24  
  24. 24. Potential Funding Structure? Matching funds: Overheads, research FCR not related to direct genebank use, capital depreciation Incentive funding: Available for activities that go beyond basic genebanking according to performance & use Fixed base funding: Basic genebank staff, operations and facility costs 25   Fixed Base Funding Incentive Funding Matching Funds
  25. 25. 26   Principles of Partnership •  Financial and performance commitment on both sides •  Based on a Business Plan which describes financing plan of the collection (including cost recovery from use) •  Agreed Acquisition and Curation Policies. Deviations are shared with the CropTrust. •  Performance targets are met before commitment is made for long-term provision of Full Fixed Base Funding •  Transparent mechanism for retraction from agreement
  26. 26. Thank  you  

×